These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

137 related items for PubMed ID: 6178415

  • 1. Effect of L-glutamine antagonists on 5-phosphoribosyl 1-pyrophosphate levels in P388 leukemia and in murine colon adenocarcinomas in vivo.
    Ardalan B, Arakawa M, Villacorte D, Jayaram H, Cooney DA.
    Biochem Pharmacol; 1982 Apr 15; 31(8):1509-13. PubMed ID: 6178415
    [Abstract] [Full Text] [Related]

  • 2. Phosphoribosyl pyrophosphate, pool size and tissue levels as a determinant of 5-fluorouracil response in murine colonic adenocarcinomas.
    Ardalan B, Villacorte D, Heck D, Corbett T.
    Biochem Pharmacol; 1982 Jun 01; 31(11):1989-92. PubMed ID: 6180752
    [No Abstract] [Full Text] [Related]

  • 3. Mechanism of resistance of a variant of P388 leukemia to L-(alpha S,5S)-alpha-amino-3-chloro-4,5-dihydro-5-isoxazoleacetic acid (acivicin).
    Jayaram HN, Ardalan B, Deas M, Johnson RK.
    Cancer Res; 1985 Jan 01; 45(1):207-12. PubMed ID: 2578092
    [Abstract] [Full Text] [Related]

  • 4. Biochemical mechanisms for the scheduled synergism of (alpha S, 5S)-2 amino-3-chloro-4,5-dihydro-5-isoxazoleacetic acid and 5-fluorouracil in P388 leukemia.
    Ardalan B, Chandrasekaran B, Hrishikeshavan HJ.
    Cancer Chemother Pharmacol; 1985 Jan 01; 15(1):44-8. PubMed ID: 2408773
    [Abstract] [Full Text] [Related]

  • 5. Uptake of glutamine antimetabolites 6-diazo-5-oxo-L-norleucine (DON) and acivicin in sensitive and resistant tumor cell lines.
    Huber KR, Rosenfeld H, Roberts J.
    Int J Cancer; 1988 May 15; 41(5):752-5. PubMed ID: 3366493
    [Abstract] [Full Text] [Related]

  • 6. Cytotoxic mechanisms of glutamine antagonists in mouse L1210 leukemia.
    Lyons SD, Sant ME, Christopherson RI.
    J Biol Chem; 1990 Jul 05; 265(19):11377-81. PubMed ID: 2358467
    [Abstract] [Full Text] [Related]

  • 7. Effect of uridine diphosphoglucose on levels of 5-phosphoribosyl pyrophosphate and uridine triphosphate in murine tissues.
    Colofiore JR, Sawyer RC, Balis ME, Martin DS.
    Pharm Res; 1989 Oct 05; 6(10):863-6. PubMed ID: 2481854
    [Abstract] [Full Text] [Related]

  • 8. Collateral sensitivity to N-(phosphonacetyl)-L-aspartic acid in a line of P388 leukemia cells selected for resistance to L-(alpha S, 5S)-alpha-amino-3- chloro-4,5-dihydro-5-isoxazoleacetic acid (acivicin).
    Ardalan B, Jayaram HN, Johnson RK.
    Cancer Res; 1983 Apr 05; 43(4):1598-601. PubMed ID: 6831405
    [Abstract] [Full Text] [Related]

  • 9. The concentration of 5-phosphoribosyl 1-pyrophosphate in monolayer tumor cells and the effect of various pyrimidine antimetabolites.
    Peters GJ, Laurensse E, Leyva A, Pinedo HM.
    Int J Biochem; 1985 Apr 05; 17(1):95-9. PubMed ID: 2581824
    [Abstract] [Full Text] [Related]

  • 10. Enhancement of antitumor activity of glutamine antagonists 6-diazo-5-oxo-L-norleucine and acivicin in cell culture by glutaminase-asparaginase.
    Rosenfeld H, Roberts J.
    Cancer Res; 1981 Apr 05; 41(4):1324-8. PubMed ID: 7214322
    [Abstract] [Full Text] [Related]

  • 11. Fluctuations in phosphoribosyl pyrophosphate levels in monolayer tumor cell lines. Effects of drugs.
    Peters GJ, Laurensse E, Leyva A, Pinedo HM.
    FEBS Lett; 1984 May 21; 170(2):277-80. PubMed ID: 6202553
    [Abstract] [Full Text] [Related]

  • 12. Sequence and schedule-dependent synergy of trimetrexate in combination with 5-fluorouracil in vitro and in mice.
    Elliott WL, Howard CT, Dykes DJ, Leopold WR.
    Cancer Res; 1989 Oct 15; 49(20):5586-90. PubMed ID: 2477146
    [Abstract] [Full Text] [Related]

  • 13. Elucidation of pathways of 5-fluorouracil metabolism in xenografts of human colorectal adenocarcinoma.
    Houghton JA, Houghton PJ.
    Eur J Cancer Clin Oncol; 1983 Jun 15; 19(6):807-15. PubMed ID: 6191988
    [Abstract] [Full Text] [Related]

  • 14. gamma-Glutamyl hydrolase from human sarcoma HT-1080 cells: characterization and inhibition by glutamine antagonists.
    Waltham MC, Li WW, Gritsman H, Tong WP, Bertino JR.
    Mol Pharmacol; 1997 May 15; 51(5):825-32. PubMed ID: 9145921
    [Abstract] [Full Text] [Related]

  • 15. Effect of de novo purine synthesis inhibitors on 5-fluorouracil metabolism and cytotoxicity.
    Cadman E, Benz C, Heimer R, O'Shaughnessy J.
    Biochem Pharmacol; 1981 Sep 01; 30(17):2469-72. PubMed ID: 21043247
    [Abstract] [Full Text] [Related]

  • 16. The efficacy of combined therapy with methotrexate and 5-fluorouracil from the view point of cellular PRPP level of L1210 cells and HeLa S3 cells.
    Kakuta H, Kanamaru R, Sato T, Ishioka C, Wakui A.
    Sci Rep Res Inst Tohoku Univ Med; 1985 Dec 01; 32(1-4):47-52. PubMed ID: 2428109
    [No Abstract] [Full Text] [Related]

  • 17. Induction of millimolar amounts of 5-phosphoribosyl-1-pyrophosphate in human erythrocytes by incubation in inosine-pyruvate-phosphate medium. A 31P-NMR study.
    Petersen A, Quistorff B.
    Biomed Biochim Acta; 1990 Dec 01; 49(2-3):S111-6. PubMed ID: 1696811
    [Abstract] [Full Text] [Related]

  • 18. Characterization of L-threonine and L-glutamine transport in murine P388 leukemia cells in vitro. Presence of an N-like amino acid transport system.
    Lazarus P, Panasci LC.
    Biochim Biophys Acta; 1986 Apr 25; 856(3):488-95. PubMed ID: 3083865
    [Abstract] [Full Text] [Related]

  • 19. Efficacy of 6-diazo-5-oxo-L-norleucine and N-[N-gamma-glutamyl-6-diazo-5-oxo-norleucinyl]-6-diazo-5-oxo-norleucine against experimental tumors in conventional and nude mice.
    Ovejera AA, Houchens DP, Catane R, Sheridan MA, Muggia FM.
    Cancer Res; 1979 Aug 25; 39(8):3220-4. PubMed ID: 572261
    [Abstract] [Full Text] [Related]

  • 20. The inhibition by 6-diazo-5-oxo-l-norleucine of glutamine catabolism of the cultured human lymphoblast.
    Willis RC, Seegmiller JE.
    J Cell Physiol; 1977 Dec 25; 93(3):375-82. PubMed ID: 22551
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 7.